Services

We work with corporate leaders to identify and develop strategies most likely to lead to business success. We augment our strategy work with analytic tools that use robust, credible methodologies and processes to help evaluate drug assets and portfolios. Our analyses highlight the risk and return of specific asset strategies and help pinpoint gaps in the pipeline in time to take action. Management can thoroughly evaluate alternatives and confidently communicate to shareholders how a chosen course of action will generate business value and achieve challenging goals.

Our strategic expertise encompasses:

• Business vision and corporate strategy
• Therapeutic area strategy
• R&D portfolio strategy
• Drug development strategy
• Commercialization strategy
• Licensing and mergers & acquisitions strategy